Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. - Wikidata - awgldk - TriplyDB

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

http://www.wikidata.org/entity/Q30805022

about

TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins Naked2 acts as a cargo recognition and targeting protein to ensure proper delivery and fusion of TGF-alpha containing exocytic vesicles at the lower lateral membrane of polarized MDCK cells.EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cells Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice Hormone action in the mammary gland MUC1: a multifunctional cell surface component of reproductive tissue epithelia Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodeling Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF Recent advances in the field of anti-cancer immunotherapy Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis Phosphatidylserine exposure is required for ADAM17 sheddase function Epidermal growth factor: a new therapeutic target in glomerular disease.Rhomboids, signalling and cell biology Catalytic activity of human ADAM33 The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts The transmembrane domain of TACE regulates protein ectodomain shedding Unraveling the microenvironmental influences on the normal mammary gland and breast cancer Phenotypic changes in dentition of Runx2 homozygote-null mutant mice Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes Essential role for ADAM19 in cardiovascular morphogenesis Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands Cross-domain inhibition of TACE ectodomain Shooting from the hip: spatial control of signal release by intracellular waves.Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage.Rapid and sensitive identification of epitope-containing peptides by direct matrix-assisted laser desorption/ionization tandem mass spectrometry of peptides affinity-bound to antibody beads.Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio.Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10 Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics.Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling.

P2860

Q24301702-945A82D7-DEC9-40C4-8925-4B18B6362F73 Q24303582-FF0604B1-A1DB-4430-B15C-B1E1DAFA9B35 Q24307953-7DD5DFB7-B916-4208-8F6C-DA2297571DDC Q24308843-0ADF961C-59FC-4C02-AAAB-716DB8820F02 Q24309589-C09E3B4B-8257-4DB0-AE18-E61BB3BFA24C Q24317214-CF3C3FEE-0C5B-429A-AA8D-537F61FD4B54 Q24529106-70D62CA9-5884-4A87-8FEE-D49D052EE6B3 Q24604954-1A45D1D9-989B-45D8-AD01-6F4166424847 Q24633038-67BE4D26-D32D-4B1C-9292-35CD4C3AD8BA Q24633569-74CC6565-4C9E-423D-9E9C-5491AACDC8C5 Q24646364-2E422345-B6C5-4D28-B654-CC8E487E543E Q24646402-784B2B22-E673-454C-BF2A-7EAEE7C3CFF3 Q24672346-4A692C2F-74EE-452C-A20B-8BB3746F7B6D Q26775602-ED40F8ED-BFC6-4316-BDB0-3F52C7C09DA4 Q26852845-D2755250-FD95-4824-A32A-C616B6FC5773 Q27317119-A92B53BA-B6CF-4C52-8EA9-53BDDC998920 Q27686898-87B53B4E-9585-4A31-A2CA-EE74A64E77A5 Q28070034-BD84FEA8-C7EB-4FAC-A2BD-53AB8A17F6E1 Q28191609-C5B7B961-5C38-485E-8C87-5C52CDFE9E51 Q28240480-97FAACC0-9C2D-4EA5-9FA7-D39D4A38AAA9 Q28258815-89E77C0D-34AF-4BA5-972F-7EBA1D58531B Q28473677-3FD97433-F498-4245-A761-E5231D6C7529 Q28508216-7D0BFA20-1C8B-4C06-9B21-EC9E827C677F Q28565754-7491373B-54D3-4AB4-84C8-0DF54040D4B0 Q28576759-744ABB8E-2E99-49E5-AD35-C5F166BB9C99 Q28577954-951E2669-C983-478D-987C-D837E568EF18 Q28594617-2F6A3947-7004-4CCB-958A-3FA6ADC4BD2D Q30443463-30610B65-C6EC-4EF2-9374-A643A7D8B214 Q30499696-8BEE918F-9AFB-48BD-9650-B91C0358B870 Q30531514-18BF63C2-E8BB-4CED-8BDD-E7D1B478E2AA Q31111797-5428D1B6-4713-4CE0-908B-8603878AE5FB Q33193697-197AB2FE-C0D3-433A-9742-0A88C2DD5E78 Q33201079-CE6AECA7-5B0A-43C6-8E1E-2FBEDB2AA713 Q33252380-7DEA665D-619E-4B87-9A54-09985C2817E5 Q33282314-98E4BA01-255F-42B2-BA9F-CC1C320CACBD Q33498106-E3870220-14C6-4C7B-AE6C-62C06309284A Q33615455-9D92CEF0-4FCB-4BC2-AF1E-201988508831 Q33615688-78BEED08-F1BF-48AF-9E08-2D61E73BD806 Q33704501-54686F7E-D204-4202-A47B-F1E0E952CF84 Q33774545-9B940B51-F0F7-4BEA-993B-EA73CB8166DE

P2860

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

http://www.wikidata.org/entity/Q30805022

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@ast

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@en

type

label

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@ast

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@en

prefLabel

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@ast

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@en

P1433

Q30805022-C6C2D00D-16B5-42FA-80F9-E7C9B858104E

P1476

Q30805022-53AA795E-8579-41F5-AD4A-5A77083D528C

P2093

Q30805022-0DF9C2FA-1BE4-43B6-84D9-9E30F7FC6BE2

Q30805022-27B4C698-38F7-4AD4-9CF1-3D5A489F69EC

Q30805022-2DE50291-F3F5-4C85-A6D1-7D870F8EAAC7

Q30805022-2FE21692-1408-4450-8879-06867BC5CB9D

Q30805022-5270311E-E169-4E18-A694-E41D16233FBF

Q30805022-70FCB0F6-3459-4A27-B145-F8E6CC143FDC

Q30805022-886AEF7D-61FD-4D54-8B0A-E39120727238

Q30805022-CC3B127F-CF05-46AD-B323-96E4193DFD3D

Q30805022-FAF04474-ED7C-4B3A-96D9-06B6D6F99115

Q30805022-FE547212-A6F4-4A2C-9CCE-75B2EFB907F1

P304

Q30805022-9B4460F7-68C1-49A4-B753-FE142E4A176B

P31

Q30805022-16DF01F1-9528-473E-A385-2C00FF7AFA04

P356

Q30805022-901243CE-3830-42F9-871F-3ADE7002A1E1

P407

Q30805022-9ABA5B71-A1CA-4BE8-8CA5-DF2262602F19

P433

Q30805022-14C18CA6-7888-4C2C-ABE2-645A9E11FCD4

P478

Q30805022-78EFC19A-2E63-4035-B143-46095F5285F4

P50

Q30805022-6ECAC5E9-A335-48B6-8AB2-AED3B60CAB96

P577

Q30805022-1D902DCD-541B-45CF-9DD5-D340F4CFA94D

P5875

Q30805022-E03248B2-DD0E-4D4D-998A-817ECF6CB9A8

P698

Q30805022-676C7743-409F-4AFA-B0AD-0A4E249B450E

P356

P1433

Journal of Biological Chemistry

P1476

Tumor necrosis factor-alpha co ...... receptor ligand availability.

@en

P2093

Beverly J Castner

http://www.w3.org/2001/XMLSchema#string

C Leann Hinkle

http://www.w3.org/2001/XMLSchema#string

Christina S Raska

http://www.w3.org/2001/XMLSchema#string

David C Lee

http://www.w3.org/2001/XMLSchema#string

Jacques J Peschon

http://www.w3.org/2001/XMLSchema#string

Mary J Gerhart

http://www.w3.org/2001/XMLSchema#string

Mary Stevenson

http://www.w3.org/2001/XMLSchema#string

Raymond J Paxton

http://www.w3.org/2001/XMLSchema#string

Roy A Black

http://www.w3.org/2001/XMLSchema#string

William E Russell

http://www.w3.org/2001/XMLSchema#string

P304

12838-12845

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M112050200

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P50

Susan Wohler Sunnarborg

P577

2002-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11537638

http://www.w3.org/2001/XMLSchema#string

P698

11823465

http://www.w3.org/2001/XMLSchema#string